Your search for Pharmaceutical products
Number of alerts found: 2549

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.09.2025

§ 130a Abs. 8 SGB V ermöglicht den Krankenkassen (KK) und pharmazeutischen Unternehmen, Rahmenrabattverträge über die zu Lasten der gesetzlichen KK abzugebenden Arzneimittel zu schließen. Die GWQ wird als Gesellschaft für Wirtschaftlichkeit und Qualität bei KK gem. § 130a Abs. 8 S. 5 SGBV für ihre Aktionärs- und Kundenkassen tätig. …

CPV: 33600000 Pharmaceutical products
Deadline:
May 10, 2027, 10 a.m.
Deadline type:
Submitting a bid
Place of execution:
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.09.2025
Awarding body:
GWQ ServicePlus AG
Award number:
Buprenorphin + Naloxon (SUT/SMT)
Publication:
Aug. 7, 2025, 6:31 a.m.
„Доставка на лекарствени продукти за нуждите на Клиники и Отделения на УСБАЛО „Проф. Иван Черноземски“ ЕАД, по обособени позиции – ЧАСТ 3“

Предметът на поръчката е периодична доставка по предварителна заявка на лекарствени продукти за нуждите на лечебния процес в Клиники и Отделения на УСБАЛO „Проф. Иван Черноземски“ ЕАД за срок от 24 месеца. Пълната информация относно техническите изисквания към изпълнението на обществената поръчка е описана и регламентирана в „Техническата спецификация“, неразделна …

CPV: 33600000 Pharmaceutical products
Place of execution:
„Доставка на лекарствени продукти за нуждите на Клиники и Отделения на УСБАЛО „Проф. Иван Черноземски“ ЕАД, по обособени позиции – ЧАСТ 3“
Awarding body:
УНИВЕРСИТЕТСКА СПЕЦИАЛИЗИРАНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ ПО ОНКОЛОГИЯ "ПРОФ. ИВАН ЧЕРНОЗЕМСКИ" ЕАД
Award number:
466136
Publication:
Aug. 7, 2025, 6:29 a.m.
Open house Arzneimittelrabattverträge zum Wirkstoff Octreotid, ATC H01CB02

Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes vom 01.10.2025 bis zum 30.09.2027 mit jederzeitiger Möglichkeit des Vertragsabschlusses (open-house-Modell). Im Open House Verfahren sind Arzneimittel entsprechend der BfArM-Liste nach § 35 Abs. 5a SGB V (Kinderarzneimittel) ausgeschlossen. …

CPV: 33600000 Pharmaceutical products
Deadline:
July 31, 2027, 11:59 p.m.
Deadline type:
Submitting a bid
Place of execution:
Open house Arzneimittelrabattverträge zum Wirkstoff Octreotid, ATC H01CB02
Awarding body:
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Award number:
AOKRPS-25-088
Publication:
Aug. 7, 2025, 6:28 a.m.
DPS ID: 859289. Konkretaus DPS pirkimo ID: 3515471

DPS buvo vykdomas konkretus pirkimas - Reagentų, antgalių ir mėgintuvėlių. Pirkimo objektas buvo skaidomas į 3 (tris) pirkimo objekto dalis, Antgaliai ir mėgintuvėliai Detalesnis aprašymas pateiktas pirkimo dokumentuose. Detalesnis aprašymas pateiktas pirkimo dokumentuose.

CPV: 33696300 Chemical reagents, 33600000 Pharmaceutical products, 38437000 Laboratory pipettes and accessories
Place of execution:
DPS ID: 859289. Konkretaus DPS pirkimo ID: 3515471
Awarding body:
Vytauto Didžiojo universitetas (PV)
Award number:
859289
Publication:
Aug. 7, 2025, 6:26 a.m.
DYNAMICKÝ NÁKUPNÍ SYSTÉM NA DODÁVKY LÉČIVÝCH PŘÍPRAVKŮ, VÝŽIV A VYBRANÝCH ZDRAVOTNICKÝCH PROSTŘEDKŮ (DNS-L178/2025)

Předmětem veřejných zakázek zadávaných v DNS budou dodávky léčivých přípravků, výživ a vybraných zdravotnických prostředků určených ke spotřebě na klinikách a odděleních Fakultní nemocnice Bulovka. Předmětem veřejné zakázky jsou průběžné a opakované dodávky léčivého přípravku s účinnou látkou DURVALUMAB z ATC skupiny L01FF03 určeného pro potřeby zadavatele v rámci poskytování …

CPV: 33600000 Pharmaceutical products, 33611000 Medicinal products for acid related disorders, 33612000 Medicinal products for functional gastrointestinal disorders, 33613000 Laxatives, 33614000 Antidiarrhoeals, intestinal anti-inflammatory/anti-infective agents, 33615000 Medicinal products used in diabetes, 33615100 Insulin, 33616000 Vitamins, 33616100 Provitamins, 33617000 Mineral supplements, 33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system, 33621000 Medicinal products for the blood and blood-forming organs, 33621100 Antithrombotic agents, 33621200 Antihaemorrhagics, 33621300 Antianaemic preparations, 33621400 Blood substitutes and perfusion solutions, 33622000 Medicinal products for the cardiovascular system, 33622100 Cardiac therapy medicinal products, 33622200 Antihypertensives, 33622300 Diuretics, 33622400 Vasoprotectives, 33622500 Antihaemorrhoidals for topical use, 33622600 Beta-blocking agents, 33622700 Calcium channel blockers, 33622800 Agents acting on the renin-angiotensin system, 33630000 Medicinal products for dermatology and the musculo-skeletal system, 33631000 Medicinal products for dermatology, 33631100 Antifungals for dermatological use, 33631110 Salicylic acids, 33631200 Emollients and protectives, 33631300 Antipsoriatics, 33631400 Antibiotics and chemotherapeutics for dermatological use, 33631500 Corticosteroids for dermatological use and dermatological preparations, 33631600 Antiseptics and disinfectants, 33631700 Anti-acne preparations, 33632000 Medicinal products for the musculo-skeletal system, 33632100 Anti-inflammatory and anti-rheumatic products, 33632200 Muscle relaxants, 33632300 Antigout preparations, 33640000 Medicinal products for the genitourinary system and hormones, 33641000 Medicinal products for the genitourinary system and sex hormones, 33641100 Gynaecological anti-infectives and antiseptics, 33641200 Other gynaecologicals, 33641300 Sex hormones and modulators of the genital system, 33641400 Contraceptives, 33641410 Oral contraceptives, 33641420 Chemical contraceptives, 33642000 Systemic hormonal preparations, excl. sex hormones, 33642100 Pituitary, hypothalamic hormones and analogues, 33642200 Corticosteroids for systemic use, 33642300 Thyroid therapy medicinal products, 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, 33651000 General anti-infectives for systemic use and vaccines, 33651100 Antibacterials for systemic use, 33651200 Antimycotics for systemic use, 33651300 Antimycobacterials, 33651400 Antivirals for systemic use, 33651500 Immune sera and immunoglobulins, 33651510 Antisera, 33651520 Immunoglobulins, 33651600 Vaccines, 33651610 Diphtheria-pertussis-tetanus vaccines, 33651620 Diphtheria-tetanus vaccines, 33651630 BCG vaccines (dried), 33651640 Measles-mumps-rubella vaccines, 33651650 Typhus vaccines, 33651660 Influenza vaccines, 33651670 Polio vaccines, 33651680 Hepatitis B vaccines, 33651690 Vaccines for veterinary medicine, 33652000 Antineoplastic and immunomodulating agents, 33652100 Antineoplastic agents, 33652200 Endocrine therapy medicinal products, 33652300 Immunosuppressive agents, 33660000 Medicinal products for the nervous system and sensory organs, 33661000 Medicinal products for the nervous system, 33661100 Anaesthetics, 33661200 Analgesics, 33661300 Antiepileptics, 33661400 Anti-Parkinson medicinal products, 33661500 Psycholeptics, 33661600 Psychoanaleptics, 33661700 Other nervous system medicinal products, 33662000 Medicinal products for sensory organs, 33662100 Ophthalmologicals, 33670000 Medicinal products for the respiratory system, 33673000 Medicinal products for obstructive airway diseases, 33674000 Cough and cold preparations, 33675000 Antihistamines for systemic use, 33680000 Pharmaceutical articles, 33681000 Teats, nipple shields and similar articles for babies, 33682000 Rubber tiles, 33683000 Rubber cushioning, 33690000 Various medicinal products, 33691000 Antiparasitic products, insecticides and repellents, 33691100 Antiprotozoals, 33691200 Anthelmintics, 33691300 Ectoparasiticides, incl. scabicides, insecticides and repellents, 33692000 Medical solutions, 33692100 Infusion solutions, 33692200 Parenteral nutrition products, 33692210 Parenteral feeding solutions, 33692300 Enteral feeds, 33692400 Perfusion solutions, 33692500 Injectable solutions, 33692510 Intravenous fluids, 33194120 Infusion supplies, 33692600 Galenical solutions, 33692700 Glucose solutions, 33692800 Dialysis solutions, 33693000 Other therapeutic products, 33693100 Toxins, 33693200 Nicotine substitutes, 33693300 Addiction treatment, 33694000 Diagnostic agents, 33695000 All other non-therapeutic products, 33696000 Reagents and contrast media, 33696100 Blood-grouping reagents, 33696200 Blood-testing reagents, 33696300 Chemical reagents, 33696400 Isotopic reagents, 33696500 Laboratory reagents, 33696600 Reagents for electrophoresis, 33696700 Urological reagents, 33696800 X-ray contrast media, 33697000 Medical preparations excluding dental consumables, 33697100 Enema preparations, 33697110 Bone reconstruction cements, 33698000 Clinical products, 33698100 Microbiological cultures, 33698200 Glands and their extracts, 33698300 Peptic substances, 15880000 Special nutritional products, 33190000 Miscellaneous medical devices and products
Place of execution:
DYNAMICKÝ NÁKUPNÍ SYSTÉM NA DODÁVKY LÉČIVÝCH PŘÍPRAVKŮ, VÝŽIV A VYBRANÝCH ZDRAVOTNICKÝCH PROSTŘEDKŮ (DNS-L178/2025)
Awarding body:
Fakultní nemocnice Bulovka
Award number:
012/2021
Publication:
Aug. 7, 2025, 6:17 a.m.
Adjudicación del Contrato Basado del Acuerdo Marco del Suministro de Medicamentos para tratar la HIPERCOLESTEROLEMIA PRIMARIA (FAMILIAR HETEROZIGÓTICA Y NO FAMILIAR) O DISPLIDEMIA MIXTA CON INHIBIDORES DE PCSK9 de la Corporació de Salut del Maresme i La Selva

Adjudicación del Contrato Basado de la Corporació de Salut del Maresme i La Selva derivado del Acuerdo Marco del Suministro de Medicamentos para tratar la HIPERCOLESTEROLEMIA PRIMARIA (FAMILIAR HETEROZIGÓTICA Y NO FAMILIAR) O DISPLIDEMIA MIXTA CON INHIBIDORES DE PCSK9 tramitado por el Consorci de Salut i d’Atenció Social de Catalunya …

CPV: 33600000 Pharmaceutical products, 33690000 Various medicinal products
Place of execution:
Adjudicación del Contrato Basado del Acuerdo Marco del Suministro de Medicamentos para tratar la HIPERCOLESTEROLEMIA PRIMARIA (FAMILIAR HETEROZIGÓTICA Y NO FAMILIAR) O DISPLIDEMIA MIXTA CON INHIBIDORES DE PCSK9 de la Corporació de Salut del Maresme i La Selva
Awarding body:
Corporació de Salut del Maresme i la Selva
Award number:
CB CSMS CSC F 3/21 – 3A
Publication:
Aug. 6, 2025, 6:34 a.m.
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Melatonin (ausschließlich in den Wirkstärken 1mg und 5mg), ATC N05CH01 für die Zeit 01.08.2023 - 31.07.2025

§ 130a Absatz 8 SGB V ermöglicht den Krankenkassen und pharmazeutischen Unternehmen, Rahmenrabattverträge über die zu Lasten der gesetzlichen Krankenkassen abzugebenden Arzneimittel zuschließen. In Hinblick auf die dafür einschlägigen gesetzlichen Vorschriften zur Vergabe öffentlicher Aufträge, findet ein regelmäßiger Prozess wirkstoffbezogener, förmlicher Vergabeverfahren nach den Regularien des 4. Teils des GWB …

CPV: 33600000 Pharmaceutical products
Place of execution:
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Melatonin (ausschließlich in den Wirkstärken 1mg und 5mg), ATC N05CH01 für die Zeit 01.08.2023 - 31.07.2025
Awarding body:
DAK-Gesundheit
Award number:
1003984 - Melatonin, (ausschließlich in den Wirkstärken 1mg und 5mg), ATC N05CH01
Publication:
Aug. 6, 2025, 6:34 a.m.
Intention notice: CT machine (phototelle CT) Naeotom Alpha to Helse Stavanger HF

Sykehusinnkjøp HF intends, on behalf of Helse Stavanger HF, to enter into an agreement with Siemens Healthcare AS for the procurement of a CT machine (photontelle CT) Naeotom Alpha to the Radiological Department at Helse Stavanger HF. Pursuant to the public procurement regulations § 13-4 first section letter b no. …

CPV: 33000000 Medical equipments, pharmaceuticals and personal care products, 33100000 Medical equipments, 33600000 Pharmaceutical products, 33700000 Personal care products, 33900000 Post-mortem and mortuary equipment and supplies
Place of execution:
Intention notice: CT machine (phototelle CT) Naeotom Alpha to Helse Stavanger HF
Awarding body:
SYKEHUSINNKJØP HF
Award number:
2025/48539
Publication:
Aug. 6, 2025, 6:25 a.m.
Fourniture de DMS Dialyse

Fourniture de DMS Dialyse Hémodialyseur à fibres capillaires en polysulfone haute perméabilité. Surface : 1,5 à 2,2m² Hémodialyseur à fibres capillaires en polysulfone moyenne perméabilité. Surface : 1,5-1,8 à 2,1m² Membrane absorbante PMMA - stérilisation gamma. Surface : 1.3 à 2.2m² Membrane absorbante PEPA. Surface : 1.8 à 2.2m² Membrane …

CPV: 33100000 Medical equipments, 33140000 Medical consumables, 33600000 Pharmaceutical products
Place of execution:
Fourniture de DMS Dialyse
Awarding body:
Centre Hospitalier d'Auxerre - Etablissement Support du GHT UNYON
Award number:
25AO001
Publication:
Aug. 6, 2025, 6:22 a.m.
Modificación 20% PNSP 2023-1-067 Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del HCSC de Madrid.

Modificación 20% PNSP 2023-1-067 Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del HCSC de Madrid. Modificación 20% PNSP 2023-1-067 Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia …

CPV: 33600000 Pharmaceutical products
Place of execution:
Modificación 20% PNSP 2023-1-067 Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del HCSC de Madrid.
Awarding body:
HOSPITAL CLINICO SAN CARLOS
Award number:
Publication:
Aug. 6, 2025, 6:21 a.m.